586 related articles for article (PubMed ID: 31699518)
21. Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators.
van de Luijtgaarden MW; Jager KJ; Stel VS; Kramer A; Cusumano A; Elliott RF; Geue C; MacLeod AM; Stengel B; Covic A; Caskey FJ
Nephrol Dial Transplant; 2013 May; 28(5):1264-75. PubMed ID: 23543592
[TBL] [Abstract][Full Text] [Related]
22. Access to and coverage of renal replacement therapy in minorities and ethnic groups in Venezuela.
Bellorin-Font E; Pernalete N; Meza J; Milanes CL; Carlini RG
Kidney Int Suppl; 2005 Aug; (97):S18-22. PubMed ID: 16014094
[TBL] [Abstract][Full Text] [Related]
23. Economics of dialysis and renal transplantation in the developing world.
Chugh KS; Jha V; Chugh S
Transplant Proc; 1999 Dec; 31(8):3275-7. PubMed ID: 10616473
[No Abstract] [Full Text] [Related]
24. Overview: end-stage renal disease in the developing world.
Barsoum RS
Artif Organs; 2002 Sep; 26(9):737-46. PubMed ID: 12197924
[TBL] [Abstract][Full Text] [Related]
25. Advances in Hemodialysis in the Last Decade in Latin America.
González-Bedat MC; Rosa-Diez G; Correa-Rotter R
Rev Invest Clin; 2023; 75(6):300-308. PubMed ID: 38154458
[TBL] [Abstract][Full Text] [Related]
26. How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?
Teerawattananon Y; Luz A; Pilasant S; Tangsathitkulchai S; Chootipongchaivat S; Tritasavit N; Yamabhai I; Tantivess S
Health Res Policy Syst; 2016 Mar; 14():21. PubMed ID: 26988562
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.
Sandoz MS; Ess SM; Keusch GW; Schwenkglenks M; Szucs TD
Swiss Med Wkly; 2004 Aug; 134(31-32):448-58. PubMed ID: 15389348
[TBL] [Abstract][Full Text] [Related]
28. End-stage renal disease in Indonesia: treatment development.
Prodjosudjadi W; Suhardjono A
Ethn Dis; 2009; 19(1 Suppl 1):S1-33-6. PubMed ID: 19484872
[TBL] [Abstract][Full Text] [Related]
29. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
30. Is renal replacement therapy for all possible in developing countries?
Aviles-Gomez R; Luquin-Arellano VH; Garcia-Garcia G; Ibarra-Hernandez M; Briseño-Renteria G
Ethn Dis; 2006; 16(2 Suppl 2):S2-70-2. PubMed ID: 16774015
[TBL] [Abstract][Full Text] [Related]
31. Gaining efficiencies: resources and demand for dialysis around the globe.
Neil N; Walker DR; Sesso R; Blackburn JC; Tschosik EA; Sciaraffia V; García-Contreras F; Capsa D; Bhattacharyya SK
Value Health; 2009; 12(1):73-9. PubMed ID: 18680485
[TBL] [Abstract][Full Text] [Related]
32. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
Prodjosudjadi W
Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
[TBL] [Abstract][Full Text] [Related]
33. Barriers to Increasing Use of Peritoneal Dialysis in Bangladesh: A Survey of Patients and Providers.
Savla D; Ahmed S; Yeates K; Matthew A; Anand S
Perit Dial Int; 2017; 37(2):234-237. PubMed ID: 28360370
[TBL] [Abstract][Full Text] [Related]
34. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
Vidal E; van Stralen KJ; Chesnaye NC; Bonthuis M; Holmberg C; Zurowska A; Trivelli A; Da Silva JEE; Herthelius M; Adams B; Bjerre A; Jankauskiene A; Miteva P; Emirova K; Bayazit AK; Mache CJ; Sánchez-Moreno A; Harambat J; Groothoff JW; Jager KJ; Schaefer F; Verrina E;
Am J Kidney Dis; 2017 May; 69(5):617-625. PubMed ID: 27955924
[TBL] [Abstract][Full Text] [Related]
35. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
De Vecchi AF; Dratwa M; Wiedemann ME
Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
[TBL] [Abstract][Full Text] [Related]
36. Burden of disease - prevalence and incidence of ESRD in selected European regions and populations.
Covic A; Schiller A
Clin Nephrol; 2010 Nov; 74 Suppl 1():S23-7. PubMed ID: 20979959
[TBL] [Abstract][Full Text] [Related]
37. How can we achieve global equity in provision of renal replacement therapy?
White SL; Chadban SJ; Jan S; Chapman JR; Cass A
Bull World Health Organ; 2008 Mar; 86(3):229-37. PubMed ID: 18368211
[TBL] [Abstract][Full Text] [Related]
38. Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas.
Ghimire A; Shah S; Chauhan U; Ibrahim KS; Jindal K; Kazancioglu R; Luyckx VA; MacRae JM; Olanrewaju TO; Quinn RR; Ravani P; Shah N; Thompson S; Tungsanga S; Vachharanjani T; Arruebo S; Caskey FJ; Damster S; Donner JA; Jha V; Levin A; Malik C; Nangaku M; Saad S; Tonelli M; Ye F; Okpechi IG; Bello AK; Johnson DW
BMC Nephrol; 2024 May; 25(1):159. PubMed ID: 38720263
[TBL] [Abstract][Full Text] [Related]
39. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
Wikström B; Fored M; Eichleay MA; Jacobson SH
Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Global Kidney Health Care Status.
Bello AK; Levin A; Tonelli M; Okpechi IG; Feehally J; Harris D; Jindal K; Salako BL; Rateb A; Osman MA; Qarni B; Saad S; Lunney M; Wiebe N; Ye F; Johnson DW
JAMA; 2017 May; 317(18):1864-1881. PubMed ID: 28430830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
